Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|January 26, 2015
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II studyRoberto Petrioli, Giandomenico Roviello, Anna Ida Fiaschi, et al.
Anti-Cancer Drugs|June 9, 2015
Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II studyRoberto Petrioli, Giandomenico Roviello, Anna Ida Fiaschi, et al.
Clinical Genitourinary Cancer|April 30, 2015
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate CancerRoberto Petrioli, Giandomenico Roviello, Anna I Fiaschi, et al.
Anticancer Research|May 13, 2015
Reduced Dose of Abiraterone Acetate with Concomitant Low-dose Prednisone in the Treatment of ≥ 85 Year-old Patients with Advanced Castrate-resistant Prostate CancerRoberto Petrioli, Edoardo Francini, Anna Ida Fiaschi, et al.
Anti-Cancer Drugs|December 19, 2019
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series studyRoberto Petrioli, Maria Antonietta Mazzei, Silvano Giorgi, et al.
Journal of Geriatric Oncology|September 1, 2019
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancerRoberto Petrioli, Pamela Torre, Guido Pesola, et al.
Cancer Biology & Therapy|February 27, 2015
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancerGiandomenico Roviello, Edoardo Francini, Armando Perrella, et al.
Anti-Cancer Drugs|January 8, 2014
Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancerEdoardo Francini, Anna Ida Fiaschi, Roberto Petrioli, et al.
Future Oncology (London, England)|August 29, 2015
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancerRoberto Petrioli, Giandomenico Roviello, Anna Ida Fiaschi, et al.
Critical Reviews in Oncology/Hematology|April 17, 2016
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysisRoberto Petrioli, Giandomenico Roviello, Laura Zanotti, et al.
Pageof 8